Publications by authors named "Wenlin Luo"

Claim this Profile
T
The Effects of Total Flavonoids of Dragon's Blood on Myocardial Ischemia-Reperfusion Injury Assessed Using Ultrasound Microbubble Imaging and Speckle Tracking Technology.
Xiangxiang Lu, Lizhen Li, Gencheng Liang, Wenlin Luo, Yan Liu

J Clin Ultrasound· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Self-Healing to Smart-Healing: A Self-Diagnosing and Self-Healing System Based on Artificial Intelligence.
Wen-Lin Luo, Yao-Yao Xu, Xiong Cheng, Fang-Zhou Wang, Da-Ying Sun

Adv Mater· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study.
Thomas Dörner, Simon J Bowman, Robert Fox, Xavier Mariette, Athena Papas, Wen-Lin Luo

Arthritis Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Benjamin A Fisher, Xavier Mariette, Athena Papas, Thomas Grader-Beck, Hendrika Bootsma, Wen-Lin Luo

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanically Adaptive Polymers Constructed from Dynamic Coordination Equilibria.
Zi-Han Zhao, Shi-Yi Chen, Pei-Chen Zhao, Wen-Lin Luo, Yan-Long Luo

Angew Chem Int Ed Engl· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visible-light-induced C(sp)-C(sp) bond formation radical/radical cross-coupling.
Haoyuan Li, Sen Li, Huimin Hu, Runbo Sun, Meixia Liu, Wenlin Luo

Chem Commun (Camb)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study.
Björn Holzhauer, Lisa V Hampson, John Paul Gosling, Björn Bornkamp, Joseph Kahn, Wen-Lin Luo

Pharm Stat· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply.
Simon J Bowman, Thomas Dorner, Xavier Mariette, Wen-Lin Luo, Wolfgang Hueber

Lancet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials.
Lisa V Hampson, Björn Holzhauer, Björn Bornkamp, Joseph Kahn, Markus R Lange, Wen-Lin Luo

Clin Pharmacol Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the assessment of the probability of success in late stage drug development.
Lisa V Hampson, Björn Bornkamp, Björn Holzhauer, Joseph Kahn, Markus R Lange, Wen-Lin Luo

Pharm Stat· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Simon J Bowman, Robert Fox, Thomas Dörner, Xavier Mariette, Athena Papas, Wen-Lin Luo

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes.
Iain P Fraser, Naomi D Neufeld, Larry A Fox, Mark S Kipnes, Tracie L Miller, Wen-Lin Luo

Pediatr Diabetes· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Julio Pascual, Stefan P Berger, Oliver Witzke, Helio Tedesco, Shamkant Mulgaonkar, Wen-Lin Luo

J Am Soc Nephrol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Use of Group Sequential Study Designs for the Test of Bioequivalence for Complicated Products.
Rajesh Krishna, Wen-Lin Luo, Patrick J Larson, Paul H Fackler

J Pharm Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment.
Tushar Garimella, Reena Wang, Wen-Lin Luo, Carey Hwang, Diane Sherman

Antivir Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone.
Tushar Garimella, Reena Wang, Wen-Lin Luo, Philip Wastall, Hamza Kandoussi

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
Pieter-Jan De Kam, Wen-Lin Luo, Larissa Wenning, Lisa Ratcliffe, Christine McCrary Sisk

Platelets· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects.
Sreeneeranj Kasichayanula, David W Boulton, Wen-Lin Luo, A David Rodrigues, Zheng Yang

Br J Clin Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of simvastatin on the pharmacokinectics of sitagliptin.
Michael Cerra, Wen-Lin Luo, Susie Xiujiang Li, Catherine Matthews, Edward A O'Neill

J Popul Ther Clin Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
Brett Lauring, Andrew K P Taggart, James R Tata, Richard Dunbar, Luzelena Caro, Wen-Lin Luo

Sci Transl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of once-daily versus twice-daily raltegravir in treatment-naive HIV-infected patients.
Matthew L Rizk, Yaming Hang, Wen-Lin Luo, Jing Su, Jing Zhao

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): a potent GPR109a agonist that lowers free fatty acids in humans.
P Douglas Boatman, Brett Lauring, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Wen-Lin Luo

J Med Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Aimee Dallob, Wen-Lin Luo, Julie Mabalot Luk, Lisa Ratcliffe, Amy O Johnson-Levonas

Platelets· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of multiple doses of clarithromycin on the pharmacokinetics of laropiprant in healthy subjects.
Ying-Hong Wang, Jules I Schwartz, Wen-Lin Luo, Patricia Jumes, Rajesh Desai

Cardiovasc Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.
Wen-Lin Luo, Tami Crumley, David Ebel, George J Atiee, Jane Royalty

J Clin Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis